Paper20147896
A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.
Dumond JB and 15 others. Clin Pharmacol Ther, 2010. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir. Papers, record 20147896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20147896
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | Major topic |
| Anti-HIV Agents | Major topic |
| Cytochrome P-450 Enzyme System | Major topic |
| Pyridines | Major topic |
| Pyrones | Major topic |
| Ritonavir | Major topic |
| Adult | |
| Area Under Curve | |
| Drug Combinations | |
| Drug Interactions | |
| Enzyme Induction | |
| Enzyme Inhibitors | |
| Female | |
| Genotype | |
| HIV Protease Inhibitors | |
| Humans | |
| Intestinal Mucosa | |
| Liver | |
| Male | |
| Pharmaceutical Preparations | |
| Phenotype | |
| Polymorphism, Single Nucleotide | |
| Sulfonamides | |
| Young Adult |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| M01 RR000046 | NCRR NIH HHS | United States | M01RR000046 | PubMed and NIH | NIH RePORTER |
| P30 A150410 | PHS HHS | United States | PubMed | PubMed | |
| K23 AI077355 | NIAID NIH HHS | United States | K23AI077355 | PubMed and NIH | NIH RePORTER |
| AI54980 | NIAID NIH HHS | United States | K23AI054980 | PubMed and NIH | NIH RePORTER |
| AI077355 | NIAID NIH HHS | United States | K23AI077355 | PubMed and NIH | NIH RePORTER |
| K23 AI054980 | NIAID NIH HHS | United States | K23AI054980 | PubMed and NIH | NIH RePORTER |
| P30 AI050410 | NIAID NIH HHS | United States | P30AI050410 | PubMed and NIH | NIH RePORTER |
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15247556 | Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. | J Acquir Immune Defic Syndr | 2004 | https://conductscience.org/library/papers/15247556 | PubMed |
| 2 | 6687705 | Variability in caffeine metabolism. | Clin Pharmacol Ther | 1983 | https://conductscience.org/library/papers/6687705 | PubMed |
| 3 | 18176328 | Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51). | J Acquir Immune Defic Syndr | 2008 | https://conductscience.org/library/papers/18176328 | PubMed |
| 4 | 16467132 | The human intestinal cytochrome P450 "pie". | Drug Metab Dispos | 2006 | https://conductscience.org/library/papers/16467132 | PubMed |
| 5 | 19369937 | Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteers. | Clin Pharmacol Ther | 2009 | https://conductscience.org/library/papers/19369937 | PubMed |
| 6 | 17698824 | Interaction between lopinavir/ritonavir and warfarin. | CMAJ | 2007 | https://conductscience.org/library/papers/17698824 | PubMed |
| 7 | 16291717 | Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail. | J Clin Pharmacol | 2005 | https://conductscience.org/library/papers/16291717 | PubMed |
| 8 | 9876810 | Potential interaction involving warfarin and ritonavir. | Ann Pharmacother | 1998 | https://conductscience.org/library/papers/9876810 | PubMed |
| 9 | 16639344 | Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. | J Acquir Immune Defic Syndr | 2006 | https://conductscience.org/library/papers/16639344 | PubMed |
| 10 | 9156694 | Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. | Pharmacogenetics | 1996 | https://conductscience.org/library/papers/9156694 | PubMed |
| 11 | 17324118 | Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System. | Pharmacogenomics | 2007 | https://conductscience.org/library/papers/17324118 | PubMed |
| 12 | 15229466 | Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers. | Clin Pharmacol Ther | 2004 | https://conductscience.org/library/papers/15229466 | PubMed |
| 13 | 16638741 | Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail. | J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/16638741 | PubMed |
| 14 | 17263554 | Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. | Mol Pharm | 2007 | https://conductscience.org/library/papers/17263554 | PubMed |
| 15 | 10509586 | Ritonavir and warfarin interaction. | AIDS | 1999 | https://conductscience.org/library/papers/10509586 | PubMed |
| 16 | 19245299 | In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates. | Curr Med Res Opin | 2009 | https://conductscience.org/library/papers/19245299 | PubMed |
| 17 | 17713975 | Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux. | Clin Pharmacokinet | 2007 | https://conductscience.org/library/papers/17713975 | PubMed |
| 18 | 14586384 | Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail". | Clin Pharmacol Ther | 2003 | https://conductscience.org/library/papers/14586384 | PubMed |
| 19 | 8738764 | Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans. | Ther Drug Monit | 1996 | https://conductscience.org/library/papers/8738764 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42137322 | AI-WAR: a novel warfarin management software with a bidirectional LSTM dosing model improves time in therapeutic range. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42137322 | PubMed |
| 40630458 | A Prediction Model of Stable Warfarin Doses in Patients After Mechanical Heart Valve Replacement Based on a Machine Learning Algorithm. | Rev Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40630458 | PubMed |
| 36416673 | Effects of a ritonavir-containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/36416673 | PubMed |
| 36353484 | Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36353484 | PubMed |
| 36221036 | The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/36221036 | PubMed |
| 35895276 | Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35895276 | PubMed |
| 35280254 | Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35280254 | PubMed |
| 35257505 | Physiologically-based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/35257505 | PubMed |
| 31581637 | Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail. | J Pers Med | 2019 | https://conductscience.org/library/papers/31581637 | PubMed |
| 31131437 | Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/31131437 | PubMed |
| 30427584 | Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor. | Clin Transl Sci | 2019 | https://conductscience.org/library/papers/30427584 | PubMed |
| 29926968 | Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis. | Br J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29926968 | PubMed |
| 29453687 | Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites. | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/29453687 | PubMed |
| 25465228 | Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers. | Eur J Drug Metab Pharmacokinet | 2016 | https://conductscience.org/library/papers/25465228 | PubMed |
| 24722393 | Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots. | Clin Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24722393 | PubMed |
| 24399676 | Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters. | Drug Metabol Drug Interact | 2014 | https://conductscience.org/library/papers/24399676 | PubMed |
| 24309307 | Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management. | Pharmaceutics | 2011 | https://conductscience.org/library/papers/24309307 | PubMed |
| 23872824 | A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail. | Eur J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23872824 | PubMed |
| 22472995 | Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22472995 | PubMed |
| 22391553 | Assessment of the pharmacokinetic interaction between eltrombopag and lopinavir-ritonavir in healthy adult subjects. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22391553 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CSF2RA | 1438 | PubTator's text mining | https://conductscience.org/library/genes/1438 | NCBI Gene |
| CYP1A2 | 1544 | PubTator's text mining | https://conductscience.org/library/genes/1544 | NCBI Gene |
| CYP2C19 | 1557 | PubTator's text mining | https://conductscience.org/library/genes/1557 | NCBI Gene |
| CYP2C9 | 1559 | PubTator's text mining | https://conductscience.org/library/genes/1559 | NCBI Gene |
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP3A5 | 1577 | PubTator's text mining | https://conductscience.org/library/genes/1577 | NCBI Gene |
| CYP3A7 | 1551 | PubTator's text mining | https://conductscience.org/library/genes/1551 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| NAT2 | 10 | PubTator's text mining | https://conductscience.org/library/genes/10 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20147896
GET https://conductscience.org/api/papers/v1/20147896/cited_by?page=2